Patents by Inventor Zineb MOUNIR

Zineb MOUNIR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CANCER HAVING GNAQ OR GNA11 GENETIC MUTATIONS WITH PROTEIN KINASE C INHIBITORS
    Publication number: 20220305008
    Abstract: The present disclosure relates in part to methods for treating non-uveal melanoma cancers having GNAQ or GNA11 genetic mutations that include administering a PKC small molecule inhibitor.
    Type: Application
    Filed: January 7, 2020
    Publication date: September 29, 2022
    Inventors: John Knox, Mark Lackner, Zineb Mounir, Carol O'Brien
  • Compositions and methods for diagnosis and treatment of prostate cancer
    Patent number: 10479997
    Abstract: The invention provides novel personalized therapies, kits, transmittable forms of information and methods for use in treating subjects having TMPRSS2:ERG positive prostate cancer, which we show is amenable to therapeutic treatment with a PRMT5 inhibitor. Kits, methods of screening for candidate PRMT5 inhibitors, and associated methods of treatment are also provided.
    Type: Grant
    Filed: December 1, 2015
    Date of Patent: November 19, 2019
    Assignee: NOVARTIS AG
    Inventors: Zineb Mounir, Raymond Pal Pagliarini
  • COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
    Publication number: 20170283807
    Abstract: The invention provides novel personalized therapies, kits, transmittable forms of information and methods for use in treating subjects having TMPRSS2:ERG positive prostate cancer, which we show is amenable to therapeutic treatment with a PRMT5 inhibitor. Kits, methods of screening for candidate PRMT5 inhibitors, and associated methods of treatment are also provided.
    Type: Application
    Filed: December 1, 2015
    Publication date: October 5, 2017
    Applicant: Novartis AG
    Inventors: Zineb MOUNIR, Raymond PAL PAGLIARINI